Treatment of SMA and Duchenne – Latest Updates
In this webinar, Sean Wallace, paediatric neurologist at Ullevål Hospital, Norway provides an updated overview of the treatment of Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD).
Topics:
-
Causes of the diagnoses
-
Diagnosis
-
Medical treatment
When it comes to medical treatment, Sean will present the types of medications currently available for SMA, as well as their effects. He will also review current treatment options being considered for Duchenne, including gene therapy, steroids, and anti-inflammatory drugs.
Target audience:
The webinar is particularly aimed at healthcare professionals, but will also be useful for others who wish to gain more knowledge about these diagnoses.
The webinar is in English.
Tuesday 4th November
11:00 - 12:00
60 min.
Sean Wallace
Senior Consultant at the Department of Pediatric Neurology, Oslo University Hospital
Speaker Sean Wallace is a senior consultant at the Department of Pediatric Neurology at Oslo University Hospital Norway, where he works with the treatment and follow-up of children with, among other conditions, Spinal Muscular Atrophy and Duchenne Muscular Dystrophy. He trained as a physician in England and has extensive clinical experience in pediatric neurology. For many years, Wallace has been involved in patient care, interdisciplinary collaboration, and teaching, and he has built solid expertise in new treatment options and research developments within the field.